Zusammenfassung
Primäre Hyperurikämie und/oder Gicht können 3 Arten von Nierenerkrankungen hervorrufen:
-
die akute Harnsäurenephropathie, verursacht durch die Ausfällung von Harnsäurekristallen im Tubuluslumen (Klinenberg et al. 1975; Kelton et al. 1978; Conger et al. 1976; Conger u. Falk 1977; Conger 1977);
-
die Harnsäurenephrolithiasis, die eine schleichendere Form des gleichen Vorgangs ist, wobei es jedoch statt zu einer diffusen Ausfällung zur Bildung von Harnsteinen im Harntrakt kommt (Gutman u. Yü 1968);
-
die chronische Gichtnephropathie, die eine chronische Form der interstitiellen Nephritis als Folge der langdauernden Ablagerung von Natriumuratkristallen im Nierenparenchym ist (Emmerson u. Row 1975; Talbott u. Terplan 1960; Berlow u. Beilin 1968; Linnane et al. 1981; Leumann u. Wegman 1983).
Übersetzt von M. Gross.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
BatumanV, MaesakaJK, Haddad B, Wedeen RP (1981) The role of lead in gout nephropathy. N Engl J Med 304: 520.
Beck LH (1986) Requiem for gouty nephropathy. Kidney Int 30: 280.
Beretta-Piccoli C, Weidman P, de Chalet R, Reubi F (1976) Hypertension associated with early stage kidney disease. Am J Med 61: 739.
Berger L, Yu T (1975) Renal function in gout. An analysis of 524 gouty subjects including long-term follow-up studies. Am J Med 59: 605.
Berger L, Yu TF, Kupfer AS, Gutman AB (1964) Effect of reducing renal arterial blood pressure by ballon catheter on urate excretion in the dog. Proc Soc Exp Biol Med 115: 58.
Berlow KA, Beilin LJ (1968) Renal disease in primary gout. Q J Med 37: 79.
Bianchi G, Ponticelli C, Bardi V et al. (1972) Role of the kidney in „salt and water dependent hypertension“ of end-stage renal disease. Clin Sci 42: 47.
Brod J (1975) Chronic renal parenchymal disease and hypertension. Kidney Int 8: S 235.
Brod J, Bahlmann J, Cachovan M, Hubrich W, Pretschner PD (1982) Mechanisms for the elevation of blood pressure in human renal disease. Hypertension 4: 839.
Brod J, Bahlman J, Cachovan M, Pretschner P (1983) Development of hypertension in renal disease. Clin Sci 64: 141.
Brown J, Mallory GK (1950) Renal changes in gout. N Engl J Med 243: 325.
Brown JJ, Dusterdieck G, Fraser R et al. (1971) Hypertension and chronic renal failure. Brit Med Bull 27: 128.
Brunner HR, Laragh JH, Baer L et al. (1972) Essential hypertension: Renin and aldosterone, heart attack and stroke. N Engl J Med 286: 441.
Cameron JS, Simmonds HA (1981) Uric acid and the kidney. J Clin Pathol 34: 1245.
Cameron JS, Simmonds HA, Webster DR et al. (1984) Problems of diagnosis and in vitro enzyme instability in an adolescent with hypoxanthine-guanine phosphoribosiltransferase deficiency presenting in acute renal failure. In: DeBruyn DHMM, Simmonds HA, Muller MM (eds) Purine metabolism in man, IVA. Plenum, New York, pp 7.
Cangiano JL, Ramirez-Muxo O, Ramirez-Gozales R, Trevino A (1976) Normal renin uremic hypertension. Study of cardiac hemodynamics, plasma volume, extracellular fluid volume and the renin angiotensin system. Arch Intern Med 136: 17.
Cannella G, Castellani A, Mioni G et al. (1977) Blood pressure control in end-stage renal disease in man: Indirect evidence of a complex pathogenic mechanism besides renin or blood volume. Clin Sci Mol Med 52: 19.
Cannon PJ, Stason WB, Demartini FE et al. (1966) Hyperuricemia in primary and renal hypertension. N Engl J Med 275: 457.
Catt KJ, Cain MD, Coghlan JP et al. (1970) Metabolism and blood levels of angiotensin II in normal subjects, renal disease and essential hypertension. Circ Res 26–27[Suppl II]: 177.
Chen YT, Coleman RA, Scheinman JI et al. (1988) Renal disease in Type I Glycogen storage disease. N Engl J Med 318: 7.
Chyrsanthakopoulos SG, Kastagir BK, Jubiz W, Kollf WJ (1972) Hypertension in patients on maintenance hemodialysis: Evaluation of peripheral renin activity and bilateral nephrectomy. Am J Med Sci 264: 9.
Ciabattoni G, Cinotti GA, Pierucci A et al. (1984) Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependance of renal function on prostacyclin. N Engl J Med 310: 279.
Coleman TG, Samar RE, Murphy WR (1979) Autoregulation versus other vasoconstriction in hypertension. Hypertension 1: 324.
Conger JD (1977) The roles of tubular fluid flow rate and urine alkalinization and osmolality in prevention of acute urate nephropathy. Cardiovasc Med 2: 1107.
Conger JD, Falk SA (1977) Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. J Clin Invest 59: 785.
Conger JD, Falk SA, Guggenheim ST, Burke TJ (1976) A micropunture study of the early phase of acute urate nephropathy. J Clin Invest 48: 681.
Craswell PW, Price J, Boyle PD et al. (1984) Chronic renal failure in gout: A marker of chronic lead poisoning. Kidney Int 26: 319.
Crittenden DR, Acherman GL (1977) Hyperuricemic acute renal failure in diseminated carcinoma. Arch Intern Med 137: 97.
Danielson H, Kornerup HJ, Olsen S, Posborg V (1983) Arterial hypertension in chronic glomerulonephritis. An analysis of 310 cases. Clin Nephrol 19: 284.
Davies DL, Schalekamp MA, Beevers DG et al. (1973) Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension with chronic renal failure. Lancet 1: 683.
DeQuattro V, Miura Y (1973) Neurogenic factors in human hypertension: Mechaninism or myth. Am J Med 55: 362.
Duncan H, Dixon AStJ (1960) Gout, familial hyperuricemia, and renal disease. Q J Med 29: 127.
Dustan HP, Tarazi RC, Bravo EL (1972) Physiology characteristic of hypertension. Am J Med 52: 610.
Emmerson BT (1968) Clinical differentation of primary gout from lead gout. Arch Rheum 11: 623.
Emmerson BT, Thompson L (1973) The spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency. Q J Med 166: 423.
Emmerson BT, Ravenscroft PJ (1975) Abnormal renal urate homeostasis in systemic disorders. Nephron 14: 62.
Emmerson BT, Row PG (1975) An evaluation of the pathogenesis of the gouty kidney. Kidney Int 8: 65.
Ferris TF, Gorden P (1968) Effect of angiotension and norepinephrine upon urate clearance in man. Am J Med 44: 359.
Fessel WJ (1979) Renal outcomes of gout and hyperuricemia. Am J Med 67: 74.
Frolich ED, Tarazi RC, Dustan HP (1971) Hemodynamic and functional mechanisms in two renal hypertension: arterial and pyelonephritis. Am J Med Sci 261: 189.
Frus T, Nielsen B, Willumsen J (1970) Total exchangeable sodium in chronic nephropathy with and without hypertension. Acta Med Scand 188: 65.
Gonella M, Mariani G (1983) Behaviour of serum urate in renal disease of varying etiology. In: De Bruyn CHMM, Simmonds HA, Müller MM (eds) Purine metabolism in man, vol 165A. Plenum, New York, p 205.
Gonik HC, Rubini ME, Gleason IO, Sommers SC (1965) The renal lesion in gout. Ann Intern Med 62: 667.
Gutkin M, Levinson GF, King AS, Lasker N (1969) Plasma renin activity in end-stage kidney disease. Circulation 40: 563.
Gutman AB, Yu T (1968) Uric acid nephrolithiasis. Am J Med 45: 756.
Heptinstall RH (1983) Diabetes mellitus and gout. In: Heptinstall RH (ed) Pathology of the kidney, 3rd ed. Little, Brown and Company, Boston Toronto, pp 1438.
Herrera Acosta J (1982) Hypertension in chronic renal disease. Kidney Int 22: 702.
Hollenberg NK, Adams DF, Soloman H et al. (1975) Renal vascular tone in essential and secondary hypertension. Medicine 5: 29.
Kelley WN, Palella TD (1987) Gout and other disorders of purine metabolism. In: Harrison TR, Principles of Internal Medicine, 11th ed, McGraw-Hill, New York, pp 1623.
Kelton J, Kelley WN, Holmes EW (1978) A rapid method for the diagnosis of acute acid nephropathy. Arch Intern Med 138: 612.
Kincaid-Smith P (1977) Renal disease and hypertension. Med Clin North Am 61: 611.
Kjellestrand CM, Campbell DC, von Hartitzsch B et al. (1974) Hyperuricemic acute renal failure. Arch Intern Med 133: 349.
Klinenberg JR, Kippen I, Bluestone R (1975) Hyperuricemic nephropathy: Pathologic features and factors influencing urate deposition. Nephron 14: 88.
Kolb FO, De Lalla OF, Gofman JW (1955) The hyperlipemia in disorders of carbohydrate metabolism: serial lipoprotein studies in diabetic acidosis with xanthomatomatosi and in glycogen storage disease. Metabolism 4: 310.
Lazarus JM, Hampers CL, Merril JP (1974) Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy. Arch Intern Med 133: 1059.
Leumann EP, Wegman W (1983) Familial nephropathy with hyperuricemia and gout. Nephron 34: 51.
Levy SB, Lilley JJ, Frigon RP, Stone RA (1977) Urinary kallikrein and plasma renin activity as determination of renal blood flow. J Clin Invest 60: 129.
Linnane JW, Burry AF, Emmerson BT (1981) Urate deposits in the renal medulla. Nephron 29: 216.
Massari PU, Hsu CH, Barnes RV et al. (1980) Familial hyperuricemia and renal disease. Arch Intern Med 140: 680.
Mitas JA, Levy SB, Holle R et al. (1978) Urinary kallikrein in the hypertension of renal parenchymal disease. N Engl J Med 299: 162.
Miurhead EE (1983) Vasodepressor renal medullary lipids. In: Dunn MJ (ed) Renal endocrinology. Williams & Wilkins, Baltimore, p 75.
Modern FWS, Meister L (1952) The kidney of gout, a clinical entity. Med Clin North Am 36: 941.
Mukhin NA, Serov UV, Maksimov NA et al. (1985) Hyperuricemic variant of latent glomerulonephritis. Abstract Ter Arkh 57(6): 43.
Newcombe DS (1973) Gouty arthritis and polycystic kidney disease. Ann Intern Med 79: 605.
Nyhan WL (1982) Inborn errors of purine metabolism. In: Cockburn F, Gitzelmann R (eds) Inborn errors of metabolism in humans. MPT, Lancaster, pp 13.
Pardo V, Perez-Stable E, Fisher ER (1968) Ultrastructural studies in hypertension: III. Gouty nephropathy. Lab Invest 18: 143.
Porter G (1983) Gouty nephropathy. Factor fiction? Am J Kidney Dis 2: 553.
Reif MC, Constantiner A, Levitt MF (1981) Chronic gouty nephropathy. A vanishing syndrome. N Engl J Med 304: 535.
Richmond JM, Kincaid-Smith P, Whitworth JA, Becker GS (1981) Familial urate nephropathy. Clin Nephrol 16: 163.
Rieselbach RE, Steele TH (1975) Intrinsic renal disease leading to abnormal urate excretion. Nephron 14: 81.
Rivera JV, Martinez-Maldonado M, Ramirez de Azellano G, Ehrlich L (1965) Association of hyperuricemia and polycystic kidney disease. Bol Assoc Med P R 57: 251.
Rosenbloom FM, Kelley WN, Carr AA, Seegmiller JE (1967) Familial nephropathy and gout in a kindred (abstract). Clin Res 15: 270.
Ruilope L, Robles RG, Bernis C et al. (1982) Role of renal prostaglandins E2 in chronic renal disease hypertension. Nephron 32: 202.
Schalekamp MADH, Schalekamp-Kuyken MPA, deMoor-Fruytier M et al. (1973 a) Interrelationship between blood pressure, renin, renin substrate, and blood volume in terminal renal failure. Clin Sci Mol Med 45: 417.
Schalekamp MA, Beevers DG, Briggs JD et al. (1973 b) Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system. Am J Med 55: 379.
Simmonds HA, Warren DJ, Cameron JS et al. (1980 a) Gout and renal failure in young women. Clin Nephrol 14: 176.
Simmonds HA, Cameron JS, Potter CF et al. (1980 b) Renal failure in young subjects with familial gout. In: Rapado A, Watts RWE, De Bruyn CHMN (eds) Purine metabolism in man. Vol III, 122 b: 15, Plenum, New York.
Simon NM, Smucker JE, O’Connor VJ Jr, delGreco F (1969) Differential uric acid excretion in essential and renal hypertension. Circulation 39: 121.
Smith MC, Dunn MJ (1981) Renal kallikrein, kinins and prostaglandins in hypertension. In: Brenner BM, Stein JH (eds) Contemporary issues in nephrology hypertension. Churchill Livingstone, New York, p 168.
Steele TH, Rieselbach RE (1975) Renal urate excretion in normal man. Nephron 14: 21.
Stokes GS, Mani MK, Stewart JH (1970) Relevance of salt, water and renin to hypertension in chronic renal failure. Br Med J 3: 126.
Talbott JH, Terplan KL (1960) The kidney in gout. Medicine 39: 405.
Thompson GR, Weiss JJ, Goldman RT, Rigg GA (1978) Familial occurrence of hyperuricemia, gout, and medullary cystic disease. Arch Intern Med 138: 1614.
Verger D, Leroux-Robert C, Ganter P, Richet G (1967) Les tophus goutteux de la medullaire renale des uremiques chroniques. Nephron 4: 356.
Vertes V, Cangiano JL, Berman LB, Gould A (1969) Hypertension in end-stage renal disease. N Engl J Med 280: 978.
Warren FJ, Leitch AG, Leggett RJ (1975) Hyperuricemic acute renal failure after epilectic seizures. Lancet II: 385.
Warren DJ, Simmonds HA, Gibson T, Naik RB (1981) Familial gout and renal failure. Arch Dis Childhood 56: 699.
Wedeen RP, Batuman V (1983) Tubulointerstitial nephritis induced by heavy metals and metabolic disturbances. In: Contran RS (ed) Tubulointerstitial nephropathies, vol 10, Contemporary Issues in Nephrology. Churchill-Livingstone, New York, p 211.
Weidman P, Maxwell MH, Lupu AN et al. (1971) Plasma renin activity and blood pressure in terminal renal failure. N Engl J Med 285: 757.
Westberg NG, Rosen E, Waidenstrom J (1979) Recessive x-linked hyperuricemia with gout and renal damage, normal activity of hypoxanthine phosphoribosyltransferase and resistance to azaguanine. Acta Med Scan 205: 163.
Wong SF, Mitchell MI, Robson V, Wilkinsen R (1978) Sodium and renin in the hypertension of early renal disease. Clin Sci Mol Med 55: 301.
Yu TF (1983) Lead nephropathy and gout. Am J Kidney Dis 2: 555.
Yu T, Berger L (1975) Renal disease in primary gout: a study of 253 gout patients with proteinuria. Semin Arthritis Rheum 4: 293.
Zollinger HU, Mihatsch MJ (1978) Renal pathology in biopsy. Springer, Berlin Heidelberg New York, p 466.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gonella, M., Calabrese, G. (1990). Gichtniere und Hypertonie. In: Zöllner, N. (eds) Hyperurikämie, Gicht und andere Störungen des Purinhaushalts. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93422-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-93422-3_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-93423-0
Online ISBN: 978-3-642-93422-3
eBook Packages: Springer Book Archive